Information Journal Paper
APA:
Copy. (2017). The efficacy and safety comparison between tenofovir and enteca vir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 42(-), 168-175. SID. https://sid.ir/paper/732807/en
Vancouver:
Copy. The efficacy and safety comparison between tenofovir and enteca vir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY[Internet]. 2017;42(-):168-175. Available from: https://sid.ir/paper/732807/en
IEEE:
Copy, “The efficacy and safety comparison between tenofovir and enteca vir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis,” INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, vol. 42, no. -, pp. 168–175, 2017, [Online]. Available: https://sid.ir/paper/732807/en